Soft tissue sarcomas rarely metastasize to the heart, with cardiac involvement seen in less than 0.03% of cases. Metastatic heart disease presents diagnostic challenges due to nonspecific symptoms, ...

Clear cell sarcoma is an uncommon and aggressive soft tissue tumour that most often arises in the tendons and aponeuroses of young adults. It is distinguished by its melanocytic features and, in many ...

Soft tissue sarcomas (STS) represent a heterogeneous group of extraskeletal mesenchymal tumors that affect individuals throughout the entire age continuum. Despite this pervasive influence, key ...

Soft tissue sarcomas are rare—only about 13,500 cases are diagnosed in the United States each year. They arise from what are called mesenchymal cells, which form the connective tissues in the body, ...

Prognostic factors in soft tissue sarcomas encompass a diverse spectrum of clinical, pathological and host-related parameters that influence patient outcomes. Increasingly, research is demonstrating ...

A study demonstrates the value of incorporating protein signatures in creating more advanced prediction tools for patient outcomes. Although the findings are preliminary and exploratory, the authors ...

Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to radiation and surgery reduced relapse risk by 43%. Results showed no ...

In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with ...

The National Comprehensive Cancer Network ® (NCCN ® ) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN ...